Document Detail


Differential effects of dofetilide, amiodarone, and class lc drugs on left and right atrial refractoriness and left atrial vulnerability in pigs.
MedLine Citation:
PMID:  11218069     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: Antiarrhythmic drugs have been shown to prolong right atrial refractoriness while data on the left atrium are not available. In pigs we have observed shorter effective refractory periods (ERP) of the left compared with the right atrium associated with a much higher left atrial vulnerability for tachyarrhythmias. Since this could suggest a different distribution of repolarizing ion channels in left and right atrium, we investigated whether antiarrhythmic drugs blocking different ion channels have a differential effect on left and right atrial ERP and left atrial vulnerability. METHODS: In pentobarbital-anesthetized pigs (n=40) we measured and compared ERPs in both atria before and after different drugs with the S1-S2 extrastimulus method at three basic cycle lengths (BCL) and assessed the inducibility of atrial fibrillation/flutter (AF/AFL) by the premature S2 stimulus. RESULTS: At the three BCL tested (240/300/400 ms) baseline ERPs were shorter in left vs. right atrium (112+/-2/124+/-2/129+/-2 ms vs. 147+/-2/163+/-2/167+/-2 ms, P<0.001). Mostly non-sustained AF/AFL induced by the S2 extrastimulus was very frequent in the left (68%) and nearly absent in the right atrium (3%). Only amiodarone, 5 mg/kg i.v., which showed a balanced increase of left and right atrial ERP (29+/-5/33+/-4/35+/-3% vs. 30+/-5/35+/-5/42+/-7%), decreased the inducibility of AF/AFL significantly (-72%, P<0.01). Dofetilide, 10 microg/kg i.v., had a stronger effect on right than left atrial ERP (36+/-4/39+/-5/46+/-10% vs. 23+/-2/22+/-7/22+/-5%, P<0.05), while flecainide, 1 mg/kg i.v., prolonged left more than right atrial ERP (58+/-15/36+/-7/40+/-7% vs. 26+/-5/24+/-5/21+/-4%, P<0.05) similar to 1 mg/ kg of propafenone (46+/-5/45+/-7/32+/-10% vs. 17+/-4/21+/-5/ 25+/-8%, P<0.05). CONCLUSION: The shorter refractoriness of the left compared with the right atrium observed in pigs was associated with a high left atrial vulnerability for tachyarrhythmias, which was reduced only by amiodarone showing a balanced increase of left and right atrial ERP. Dofetilide was stronger on right atrial ERP, flecainide and propafenone on left atrial ERP. These differences suggest a differential distribution of repolarizing ion channels between left and right atrium with possible relevance for the antiarrhythmic efficacy of drugs.
Authors:
K J Wirth; K Knobloch
Related Documents :
12137349 - The morphology of the specialized atrioventricular junctional area: the evolution of un...
9362409 - Thromboembolism in chronic atrial flutter: is the risk underestimated?
12382079 - Electrophysiological and antiarrhythmic effects of the novel i(kur) channel blockers, s...
1811869 - Narrow complex tachycardias. differential diagnosis and management.
15772779 - Left atrial functions after myocardial infarction.
19573939 - Nicorandil ameliorates impulse conduction disturbances during ischemia in isolated arte...
2432519 - Importance of atrial electrophysiology in the work-up of cerebral ischemic attacks.
1510509 - Composite valve graft replacement of the proximal aorta: comparison of techniques in 34...
15085059 - Sustained improvement of cardiac function and prevention of cardiac remodeling after lo...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Naunyn-Schmiedeberg's archives of pharmacology     Volume:  363     ISSN:  0028-1298     ISO Abbreviation:  Naunyn Schmiedebergs Arch. Pharmacol.     Publication Date:  2001 Feb 
Date Detail:
Created Date:  2001-02-19     Completed Date:  2001-05-03     Revised Date:  2003-11-14    
Medline Journal Info:
Nlm Unique ID:  0326264     Medline TA:  Naunyn Schmiedebergs Arch Pharmacol     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  166-74     Citation Subset:  IM    
Affiliation:
DG Cardiovascular Diseases, Aventis Pharma, Industriepark Höchst, Frankfurt am Main, Germany. klaus.wirth@aventis.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amiodarone / pharmacology*,  therapeutic use
Animals
Anti-Arrhythmia Agents / pharmacology*,  therapeutic use
Atrial Fibrillation / drug therapy
Atrial Flutter / drug therapy
Atrial Function, Left / drug effects*,  physiology
Atrial Function, Right / drug effects*,  physiology
Flecainide / pharmacology,  therapeutic use
Male
Phenethylamines / pharmacology*,  therapeutic use
Propafenone / pharmacology,  therapeutic use
Sulfonamides / pharmacology*,  therapeutic use
Swine
Chemical
Reg. No./Substance:
0/Anti-Arrhythmia Agents; 0/Phenethylamines; 0/Sulfonamides; 115256-11-6/dofetilide; 1951-25-3/Amiodarone; 54063-53-5/Propafenone; 54143-55-4/Flecainide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Characterization of the locomotor activity-inhibiting effect of nociceptin/orphanin FQ in mice.
Next Document:  Differences in electromechanical coupling between bradykinin and the nonpeptide kinin B2 receptor ag...